Altamont Pharmaceutical Holdings LLC 13D and 13G filings for Galera Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-04-03 08:08 am Sale | 2024-04-01 | 13G | Galera Therapeutics, Inc. GRTX | Altamont Pharmaceutical Holdings LLC | 0 0.000% | -5,280,000 (Position Closed) | Filing |
| 2023-11-13 2:24 pm Purchase | 2023-10-31 | 13G | Galera Therapeutics, Inc. GRTX | Altamont Pharmaceutical Holdings LLC | 5,280,000 12.020% | 5,280,000 (New Position) | Filing |